By GREGORY ZELLER // German venture capitalists have locked and loaded a Stony Brook University spinoff’s next-generation weapon against malignant tumors. Munich-based VC firm TVM Capital Life Science – whose…
Onward and upward: Welcome to Wednesday, eager entrepreneurs and intrepid innovators, and the midpoint of this latest wintry workweek. Pet peeves: It’s Jan. 22 out there – National Answer…
Turning point: Welcome to Wednesday, dear readers, and the midpoint of another productive week in Long Island socioeconomic innovation. A special hello to freshly minted newsletter subscribers David, Nina, Mark,…